Published in Surg Neurol on July 01, 2006
Current management of choroid plexus carcinomas. Neurosurg Rev (2013) 0.98
Choroid plexus papillomas: advances in molecular biology and understanding of tumorigenesis. Neuro Oncol (2012) 0.96
Spinal drop metastasis from a posterior fossa choroid plexus papilloma. J Korean Neurosurg Soc (2007) 0.95
Choroid Plexus Tumors: Experience of 10 Cases with Special References to Adult Cases. Neurol Med Chir (Tokyo) (2015) 0.75
Choroid plexus papilloma of the fourth ventricle in a septuagenarian. J Neurosci Rural Pract (2012) 0.75
Atypical transformation in sacral drop metastasis from posterior fossa choroid plexus papilloma. BMJ Case Rep (2012) 0.75
Imaging findings of extraventricular choroid plexus papillomas: A study of 10 cases. Oncol Lett (2016) 0.75
A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med (2014) 9.19
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. J Clin Oncol (2013) 3.52
Conflicting pathology reports: a diagnostic dilemma. J Neurosurg (2014) 1.98
Congenital partial aplasia of the posterior arch of the atlas causing myelopathy: case report and review of the literature. Spine (Phila Pa 1976) (2003) 1.86
Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Clin Cancer Res (2007) 1.31
Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors. Cancer (2008) 1.27
Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha. Cancer Chemother Pharmacol (2010) 1.21
Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme. Cancer (2008) 1.18
Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res (2006) 1.13
Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer (2007) 1.13
Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. J Neurosurg (2009) 1.12
Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors. Appl Immunohistochem Mol Morphol (2006) 1.09
Transient postictal MRI changes in patients with brain tumors may mimic disease progression. Surg Neurol (2006) 1.08
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131. Neuro Oncol (2008) 1.06
Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurg Rev (2007) 1.04
Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients. Neurosurgery (2005) 1.04
WHO Grade II and III supratentorial hemispheric ependymomas in adults: case series and review of treatment options. J Neurooncol (2008) 1.03
Molecular genetics of meningiomas. Neurosurg Focus (2005) 1.00
Subependymomas: an analysis of clinical and imaging features. Neurosurgery (2006) 1.00
Surgical considerations regarding giant dilations of the perivascular spaces. J Neurosurg (2004) 1.00
Role of stereotactic radiosurgery in the treatment of brain metastases. Am J Clin Oncol (2005) 0.96
Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg (2004) 0.95
Intracranial meningiomas: diagnosis and treatment. Expert Rev Neurother (2004) 0.94
Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases. Cancer (2007) 0.94
Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer (2007) 0.93
Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma. Clin Nucl Med (2012) 0.92
Oligodendroglioma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors. Case report with histological and molecular differentiation of the tumors and review of the literature. J Neurosurg (2004) 0.92
Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities. Surg Neurol Int (2013) 0.92
Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line? J Neurooncol (2011) 0.92
In vivo characterization of several rodent glioma models by 1H MRS. NMR Biomed (2011) 0.92
A comparison of the cell lines used in meningioma research. Surg Neurol (2008) 0.91
ELTD1, a potential new biomarker for gliomas. Neurosurgery (2013) 0.91
Aberrant signaling pathways in meningiomas. J Neurooncol (2010) 0.91
Preliminary use of differential scanning calorimetry of cerebrospinal fluid for the diagnosis of glioblastoma multiforme. J Neurooncol (2011) 0.90
A practical review of prognostic correlations of molecular biomarkers in glioblastoma. Neurosurg Focus (2015) 0.90
A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation. J Neurosurg (2008) 0.89
Conformity of LINAC-based stereotactic radiosurgery using dynamic conformal arcs and micro-multileaf collimator. Int J Radiat Oncol Biol Phys (2008) 0.88
Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development. J Neurooncol (2007) 0.88
Meningioma of the jugular foramen: glomus jugulare mimic and surgical challenge. Laryngoscope (2004) 0.88
Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery. Cancer (2008) 0.87
Experimental validation of 5 in-silico predicted glioma biomarkers. Neuro Oncol (2013) 0.86
Central nervous system cancers: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2005) 0.85
A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II. In vivo results. Phys Med Biol (2010) 0.85
Long-term response in high-grade optic glioma treated with medically induced hypothyroidism and carboplatin: a case report and review of the literature. Anticancer Drugs (2013) 0.85
New approaches for the treatment of refractory meningiomas. Cancer Control (2003) 0.85
Hemodynamic response imaging: a potential tool for the assessment of angiogenesis in brain tumors. PLoS One (2012) 0.85
Intracranial extramedullary hematopoiesis: brief review of response to radiation therapy. Am J Hematol (2005) 0.84
Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007. Neuro Oncol (2013) 0.84
Carcinomatous meningitis as the presenting manifestation of gallbladder carcinoma: case report and review of the literature. J Neurooncol (2004) 0.83
The impact of enrollment in clinical trials on survival of patients with glioblastoma. J Clin Neurosci (2012) 0.82
Extraneural metastatic medulloblastoma in an adult. J Neurooncol (2006) 0.82
Differential scanning calorimetry of gliomas: a new tool in brain cancer diagnostics? Neurosurgery (2013) 0.82
Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme. J Neurooncol (2010) 0.81
Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma. Neurosurg Focus (2014) 0.81
Silencing of HIF-1alpha by RNA interference in human glioma cells in vitro and in vivo. Methods Mol Biol (2009) 0.81
Surgical therapies in brain metastasis. Semin Oncol (2007) 0.80
Classification of tumor area using combined DCE and DSC MRI in patients with glioblastoma. J Neurooncol (2014) 0.79
A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149). J Neurooncol (2007) 0.79
Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme. J Neurooncol (2012) 0.79
Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas. Neurosurg Focus (2015) 0.79
Osteochondroma of the cervical spine--a surprising finding in a liver transplanted patient with polyneuropathy and polyradiculitis: case report. Surg Neurol (2002) 0.78
Multimodality management of brain metastases in metastatic melanoma patients. Expert Rev Anticancer Ther (2007) 0.77
Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas. Neurosurg Focus (2007) 0.77
Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors. Neurosurg Focus (2007) 0.77
Automatic multi-modal MR tissue classification for the assessment of response to bevacizumab in patients with glioblastoma. Eur J Radiol (2012) 0.77
The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors. Semin Oncol (2009) 0.77
RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model. J Neurosurg (2014) 0.76
Acute myopia and angle-closure glaucoma induced by topiramate. Neurology (2004) 0.76
Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro. Neurosurgery (2006) 0.76
Image guidance for brain metastases resection. Surg Neurol Int (2012) 0.76
Salvage chemotherapy with CPT-11 for recurrent temozolomide-refractory anaplastic astrocytoma. Cancer (2008) 0.76
Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397). Am J Clin Oncol (2016) 0.75
Hypophysial transposition (hypophysopexy) for radiosurgical treatment of pituitary tumors involving the cavernous sinus. Technical note. Neurosurg Focus (2003) 0.75
Primary spinal yolk sac tumor with brain metastasis: case report and review of the literature. J Neurooncol (2006) 0.75
Reversible diplopia induced by high-dose intravenous IL-2 therapy. Clin Adv Hematol Oncol (2004) 0.75
The lasso technique for posterior C1-C2 fusion. Neurosurgery (2007) 0.75
Trial To Survive: The Impact of Enrollment in Clinical Trials on Survival of Patients with Glioblastoma: 975. Neurosurgery (2009) 0.75
Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. J Neurosurg (2005) 0.75
Pleomorphic liposarcoma originating from intracranial dura mater. J Neurooncol (2009) 0.75
Human cerebral blood volume measurements using dynamic contrast enhancement in comparison to dynamic susceptibility contrast MRI. Neuroradiology (2015) 0.75
Intracerebral amyloidoma can mimic high-grade glioma on magnetic resonance imaging and spectroscopy. Arch Neurol (2006) 0.75
The Impact of the Endovascular Treatment of Cerebral Aneurysms on Headaches. Neurologist (2017) 0.75
Surgical strategies for recurrent craniofacial meningiomas. Neurosurgery (2006) 0.75
A common sense approach to radiotherapy planning of glioblastoma multiforme situated in the temporal lobe. Int J Radiat Oncol Biol Phys (2008) 0.75